Zobrazeno 1 - 2
of 2
pro vyhledávání: '"the WHO 2030 elimination goals"'
Autor:
Popping, Stephanie, Verwijs, R, Cuypers, L, Claassen, Mark, van den Berk, GE, De Weggheleire, A, Arends, JEA, Boerekamps, Anne, Molenkamp, Richard, Koopmans, Marion, Verbon, Annelies, Boucher, Charles, Rijnders, Bart, Vijver, David, Lauw, F, Posthouwer, D, Hullegie, S, Bierman, W, Dofferhof, A, Kootstra, GJ, Leyten, E, Hollander, Jessica, van Kasteren, M, Soutekouw, R, Ammerlaan, H, Florence, E
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases, 71(8), E215-E217. Oxford University Press
Clinical Infectious Diseases, 71(8), E215-E217. Oxford University Press
The transmission of direct-acting antiviral resistance-associated substitutions (RAS) could hamper hepatitis C virus (HCV) cure rates and elimination efforts. A phylogenetic analysis of 87 men who have sex with men recently infected with HCV genotype
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6daaef0cbc11e409346fdd4f69536859
https://lirias.kuleuven.be/handle/20.500.12942/707615
https://lirias.kuleuven.be/handle/20.500.12942/707615
Autor:
Popping S; Department of Viroscience, Erasmus Medical Center , University Medical Center, Rotterdam, The Netherlands., Verwijs R; Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Center, University Medical Center, Rotterdam, The Netherlands., Cuypers L; Laboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Kristelijke Universiteit Leuven, Leuven, Belgium.; Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium., Claassen MA; Department of Internal Medicine and Infectious Diseases, Rijnstate Ziekenhuis, Arnhem, The Netherlands., van den Berk GE; Department of Internal Medicine and Infectious Diseases, Onze lieve vrouwe gasthhuis, Amsterdam, The Netherlands., De Weggheleire A; Department of Clinical Science, Institute of Tropical Medicine Antwerp, Antwerp, Belgium., Arends JE; Department of Internal Medicine and Infectious Diseases, Universitair Medisch Centrum Utrecht, Utrecht University, Utrecht, The Netherlands., Boerekamps A; Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Center, University Medical Center, Rotterdam, The Netherlands., Molenkamp R; Department of Viroscience, Erasmus Medical Center , University Medical Center, Rotterdam, The Netherlands., Koopmans MP; Department of Viroscience, Erasmus Medical Center , University Medical Center, Rotterdam, The Netherlands., Verbon A; Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Center, University Medical Center, Rotterdam, The Netherlands., Boucher CAB; Department of Viroscience, Erasmus Medical Center , University Medical Center, Rotterdam, The Netherlands., Rijnders BJ; Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Center, University Medical Center, Rotterdam, The Netherlands., van de Vijver DAMC; Department of Viroscience, Erasmus Medical Center , University Medical Center, Rotterdam, The Netherlands.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2020 Nov 05; Vol. 71 (8), pp. e215-e217.
